For quite some time, Selective Serotonin Reuptake Inhibitors (SSRI’s) have been linked to an exhaustive array of congenital birth defects. Researchers are currently aware of SSRI pregnancy side effects including club foot and cleft palate, cranial and skeletal issues, heart defects and several other serious conditions. According to a new... Read more »

Blue Cross/ Blue Shield of Massachusetts has taken legal action against pharmaceutical giant Takeda, claiming the company failed to warn consumers and the medical community about the association between Actos and bladder cancer. The healthcare provider is now seeking compensation for costs of bladder cancer treatment for hundreds of their... Read more »

All testosterone therapy lawsuits filed in U.S. District Courts nationwide, alleging injuries because of Low T treatments, will now go before one judge in the Northern District of Illinois in centralized litigation known as “multidistrict litigation” or MDL. This move comes on the heels of June 6 order by a... Read more »

Angiotensin II type 1 receptor blockers (ARBs) are commonly used in the treatment of hypertension (high blood pressure) and heart failure. Benicar, manufactured by Daiichi Sankyo, is one of the more widely prescribed ARBs since its FDA approval in 2002. Also known by its generic name olmesartan medoxomil, Benicar has... Read more »

The atypical antipsychotic Risperdal continues to fuel litigation, as scores of male patients claim they developed breasts after taking the drug as children and adolescents. Court dockets indicate some 500 Risperdal lawsuits pending against pharmaceutical giant Johnson & Johnson, which has already settled a handful of claims (under confidential terms)... Read more »

The makers of several testosterone supplements are facing an impending class action lawsuit filed in California District Court early last month. The testosterone class action lawsuit raises several counts against manufacturers of over-the-counter products containing the chemical Testofen and asserts many of the claims made by these manufacturers are bogus, exaggerated... Read more »

On May 21, 2014, Fresenius Medical Care announced an expanded Naturalyte recall due to bacterial contamination.  The product recall was first issued in April after Halomonas bacteria was found in several lots of the dialysate additive.  The amended Class I recall now affects 56 lots of Naturalyte. The acid concentrates,... Read more »

In a statement issued on May 28, 2014, the pharmaceutical giant Boehringer Ingelheim announced that they had reached a settlement agreement with plaintiffs who filed lawsuits with regard to side effects from Pradaxa, a medication designed and manufactured by the company. The Pradaxa settlement involves a payout of $650 million,... Read more »

On Thursday, May 22, jurors in the Las Vegas Regional Justice Center handed down a defense verdict for Japanese drug maker Takeda, in an Actos trial that has been closely monitored across the nation. The case was brought by two elderly women — Bertha Triana and Delores Cipriano – both... Read more »

In the face of compelling evidence that “Low T therapy,” testosterone producing drugs increase chances of strokes and heart attacks, doctors with apparent vested ties to the industry are now claiming the opposite: that such drugs actually help prevent heart attacks. After it recently formed to take on “unnecessary” concerns... Read more »